Ixekizumab (Anti-CTLA-8 / IL-17a)
Product Specifications
CAS Number
1143503-69-8
Synonyms
LY2439821
SKU
C00618-1mg
Target
Interleukins
Applications
Immunology & Inflammation
Additionnal Information
Ixekizumab (Anti-CTLA-8 / IL-17a) is a humanized IgG4 monoclonal antibody that selectively binds and neutralizes interleukin IL-17A (KD<3 pM) . Ixekizumab has the potential to be used in research on plaque psoriasis. MW: 146.44 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
bsm-52384R-PE-Cy7-01 20 µL
CD63 Recombinant Antibody, PE-Cy7 Conjugated
Sign In for Pricing
View Details 
bsm-52384R-PE-Cy7-02 100 µL
CD63 Recombinant Antibody, PE-Cy7 Conjugated
Sign In for Pricing
View Details 
MBS7195120 Inquire
Rabbit anti-Drosophila melanogaster (Fruit fly) KEBAB Polyclonal Antibody
Sign In for Pricing
View Details 